The National Comprehensive Cancer Network suggested that older women with low‐risk breast cancer (LRBC; i.e., early‐stage, node‐negative, and estrogen receptor‐positive) could omit adjuvant radiation treatment (RT) after breast‐conserving surgery (BCS) if they were treated with hormone therapy. This evidence concerns the gene ESR1 and breast carcinoma.